PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology

PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology

PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging, and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professi...

Full description

Bibliographic Details
Main Authors:	Richard H. Wiggins, John M. Hoffman, Gabriel C. Fine, Matthew F. Covington, Ahmed Ebada Salem, Bhasker R. Koppula, Kathryn A. Morton
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Cancers
Subjects:	PET FDG head and neck cancer brain tumors squamous cell carcinoma cervical esophageal cancer
Online Access:	https://www.mdpi.com/2072-6694/14/11/2726

Similar Items

PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies
by: Bhasker R. Koppula, et al.
Published: (2022-05-01)

PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors
by: Gabriel C. Fine, et al.
Published: (2022-06-01)

PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies
by: Matthew F. Covington, et al.
Published: (2022-05-01)

PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies
by: Ahmed Ebada Salem, et al.
Published: (2022-11-01)

PET-CT in Clinical Adult Oncology—IV. Gynecologic and Genitourinary Malignancies
by: Ahmed Ebada Salem, et al.
Published: (2022-06-01)

Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI
by: Christian Martin Meerwein, et al.
Published: (2015-02-01)

Positron Emission Tomography (PET) in Oncology
by: Andrea Gallamini, et al.
Published: (2014-09-01)

Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
by: C. Pisani, et al.
Published: (2021-03-01)

PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area
by: Antoine Verger, et al.
Published: (2022-02-01)

Standardized classification schemes in reporting oncologic PET/CT
by: Vanessa Murad, et al.
Published: (2023-01-01)

Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles
by: Tim Van den Wyngaert, et al.
Published: (2020-08-01)

Non-FDG PET/CT in Diagnostic Oncology: a pictorial review
by: Francesco Giammarile, et al.
Published: (2019-11-01)

Corrigendum: Standardized classification schemes in reporting oncologic PET/CT
by: Vanessa Murad, et al.
Published: (2023-11-01)

Head and Neck Cancer Segmentation in FDG PET Images: Performance Comparison of Convolutional Neural Networks and Vision Transformers
by: Xiaofan Xiong, et al.
Published: (2023-10-01)

Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation
by: Yimin Li, et al.
Published: (2019-02-01)

Application of FDG-PET/CT in Radiation Oncology
by: Jun eLi, et al.
Published: (2013-04-01)

Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer
by: Simone Wegen, et al.
Published: (2024-04-01)

Recent advances of PET imaging in clinical radiation oncology
by: M. Unterrainer, et al.
Published: (2020-04-01)

Early post-treatment 18F-FDG PET/CT for predicting radiation-induced hypothyroidism in head and neck cancer
by: Hsi-Huei Lu, et al.
Published: (2022-10-01)

Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
by: Hyunjong Lee, et al.
Published: (2022-06-01)

An incidental male breast cancer of 18F-FDG PET/CT scanning for esophageal cancer
by: Wenyu Shi, et al.
Published: (2023-04-01)

Integration of 18-FDG PET/CT in the Initial Work-Up to Stage Head and Neck Cancer: Prognostic Significance and Impact on Therapeutic Decision Making
by: Jean-Christophe Leclere, et al.
Published: (2020-06-01)

Can the Efficacy of [<sup>18</sup>F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
by: Hazel O’Neill, et al.
Published: (2019-01-01)

Efficacy of 4′-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study
by: Masatoshi Hotta, et al.
Published: (2019-01-01)

Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status
by: Mercedes Porosnicu, et al.
Published: (2022-08-01)

Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy
by: Frederik Soffers, et al.
Published: (2022-06-01)

Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: a pilot study
by: Steve Durante, et al.
Published: (2020-05-01)

Physiological myocardial 18F-FDG uptake pattern in oncologic PET/CT: comparison with findings in cardiac sarcoidosis
by: Takashi Norikane, et al.
Published: (2024-01-01)

Recent and Current Advances in FDG-PET Imaging within the Field of Clinical Oncology in NSCLC: A Review of the Literature
by: Kaoru Kaseda
Published: (2020-08-01)

Use of PET Imaging in Neuro-Oncological Surgery
by: Adrien Holzgreve, et al.
Published: (2021-04-01)

Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences
by: Kumar K. Shashi, et al.
Published: (2020-01-01)

Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
by: Lianshuang Xia, et al.
Published: (2023-02-01)

Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx
by: Mindaugas Grybauskas, et al.
Published: (2014-01-01)

Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
by: Xin Xu, et al.
Published: (2021-07-01)

Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy
by: Chia-Hsin Lin, et al.
Published: (2020-03-01)

Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)
by: Abrahim Al-Mamgani, et al.
Published: (2023-11-01)

Comparable Accuracy of Quantitative and Visual Analyses of [<sup>18</sup>F]FDG PET/CT for the Detection of Lymph Node Metastases from Head and Neck Squamous Cell Carcinoma
by: Philippe d’Abadie, et al.
Published: (2023-08-01)

Lymph Node Yield and Ratio in Selective and Modified Radical Neck Dissection in Head and Neck Cancer—Impact on Oncological Outcome
by: Sean C. Sheppard, et al.
Published: (2021-05-01)

PET/MRI in Oncological Imaging: State of the Art
by: Usman Bashir, et al.
Published: (2015-07-01)

Lipid metabolism marker CD36 is associated with 18FDG-PET/CT false negative lymph nodes in head and neck squamous cell carcinoma
by: Xiaoyan Meng, et al.
Published: (2023-05-01)